Immunome (IMNM) SEC Filings & 10K Form

$14.27
-0.39 (-2.66%)
(As of 04/24/2024 ET)

Recent Immunome SEC Filings

DateFilerForm TypeView
04/03/2024
3:40 PM
Immunome (Filer)
Form S-3ASR
03/28/2024
3:04 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
3:06 PM
Immunome (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2024
7:05 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
8:07 PM
Horn Kinney (Reporting)
Immunome (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/21/2024
8:10 PM
Horn Kinney (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
1:10 PM
Alpine Global Management, LLC (Filed by)
Immunome (Subject)
Form SC 13G/A
02/06/2024
7:05 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
8:18 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
7:50 PM
Immunome (Issuer)
Stoneman Sandra G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
7:53 PM
Immunome (Issuer)
Rosett Max (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
4:27 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
6:05 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
4:33 PM
Immunome (Issuer)
SCHAFER CAROL (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/04/2024
4:37 PM
Immunome (Issuer)
SCHAFER CAROL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:40 PM
Immunome (Issuer)
Lapetina Bob (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
7:05 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
4:00 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2023
7:35 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2023
6:24 PM
Immunome (Issuer)
Roberts Phil Noland (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/15/2023
6:28 PM
Immunome (Issuer)
Roberts Phil Noland (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
8:08 PM
Higgins Jack (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2023
11:15 PM
Immunome (Filer)
Form EFFECT
11/15/2023
5:03 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
3:52 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
3:23 PM
BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/09/2023
3:25 PM
BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2023
7:00 AM
Immunome (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2023
7:30 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2023
5:30 PM
Immunome (Issuer)
Lechleider Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2023
5:32 PM
Boylan James P (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2023
5:35 PM
Barchas Isaac (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/20/2023
3:12 PM
Immunome (Issuer)
Lechleider Robert (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/12/2023
8:56 PM
Barchas Isaac (Reporting)
Immunome (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/12/2023
5:33 PM
Higgins Jack (Reporting)
Immunome (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/12/2023
5:36 PM
Immunome (Issuer)
Rosett Max (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/12/2023
4:15 PM
Immunome (Subject)
Redmile Group, LLC (Filed by)
Form SC 13G
10/12/2023
3:39 PM
Immunome Aggregator, LP (Filed by)
Immunome (Subject)
Form SC 13D
10/12/2023
3:46 PM
Boylan James P (Reporting)
Immunome (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/12/2023
3:02 PM
Barchas Isaac (Filed by)
Immunome (Subject)
Form SC 13D
10/12/2023
11:25 AM
EcoR1 Capital, LLC (Filed by)
Immunome (Subject)
Form SC 13G
The Hard Truth About Investing For Retirement (Ad)

Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.

Click To Access This Powerful Training Right Now!
10/04/2023
4:28 PM
Immunome (Issuer)
PRENDERGAST FRANKLYN G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2023
4:29 PM
Immunome (Issuer)
Turner Bruce (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2023
4:32 PM
Immunome (Issuer)
Turner Bruce (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2023
4:34 PM
Immunome (Issuer)
SIEGALL CLAY B (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2023
4:35 PM
Immunome (Issuer)
SIEGALL CLAY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2023
5:56 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2023
4:50 PM
Immunome (Issuer)
RAPP MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/21/2023
3:03 PM
Immunome (Subject)
Form 425
09/21/2023
3:01 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2023
11:15 PM
Immunome (Filer)
Form EFFECT
08/28/2023
8:10 AM
Immunome (Filer)
Form 424B3
08/25/2023
5:38 AM
Immunome (Filer)
Form S-4/A
08/09/2023
7:27 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2023
7:00 AM
Immunome (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/07/2023
7:39 AM
Immunome (Subject)
MorphImmune Inc. (Filed by)
Form SC 13D
07/05/2023
4:12 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2023
4:15 PM
Immunome (Subject)
Form 425
06/29/2023
3:45 PM
Immunome (Subject)
Form 425
06/29/2023
8:08 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/29/2023
8:10 AM
Immunome (Subject)
Form 425
06/13/2023
4:00 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2023
3:47 PM
Giesing Dennis H (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
3:48 PM
Immunome (Issuer)
WAGENHEIM PHILIP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
3:51 PM
Immunome (Issuer)
PRENDERGAST FRANKLYN G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
3:52 PM
BARON RICHARD A (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
3:54 PM
Immunome (Issuer)
LAMATTINA JOHN L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
3:55 PM
Immunome (Issuer)
Lefenfeld Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
3:56 PM
Immunome (Issuer)
Sarma Purnanand D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
3:57 PM
Immunome (Issuer)
ROBINSON MATTHEW K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
3:58 PM
Immunome (Issuer)
Roche Corleen M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
4:01 PM
Immunome (Issuer)
Stoneman Sandra G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2023
7:19 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2023
6:30 AM
Immunome (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:IMNM) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners